A derangement of the maternal lipid profile is associated with an elevated risk of congenital heart disease in the offspring

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 6, 2012, Pages 477-485

  Smedts, H P M ^a   van Uitert, E M ^a   Valkenburg, O ^a   Laven, J S E ^a   Eijkemans, M J C ^a   Lindemans, J ^a   Steegers, E A P ^a   Steegers Theunissen, R P M ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Birth defect; Cholesterol; Congenital heart defects; Lipoproteins; Risk factors

Indexed keywords

APOLIPOPROTEIN B; FOLIC ACID; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD; BODY MASS; CASE CONTROL STUDY; CHILD; CONGENITAL HEART MALFORMATION; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERHOMOCYSTEINEMIA; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RISK; RISK FACTOR; STATISTICAL MODEL;

ADULT; APOLIPOPROTEINS B; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL, LDL; FEMALE; FOLIC ACID; HEART DEFECTS, CONGENITAL; HOMOCYSTEINE; HUMANS; HYPERGLYCEMIA; HYPERHOMOCYSTEINEMIA; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK FACTORS; YOUNG ADULT;

EID: 84861198027     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.07.016     Document Type: Article

References (40)

1. March of Dimes Birth Defects Foundation Global report on birth defects. The hidden toll of dying and disabled children 2006, White Plains, New York, USA, p. 28.
2. Botto L.D., Correa A., Erickson J.D. Racial and temporal variations in the prevalence of heart defects. Pediatrics 2001, 107:E32.
3. Ray J.G., O'Brien T.E., Chan W.S. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM 2001, 94:435-444.
4. Gilboa S.M., Correa A., Botto L.D., Rasmussen S.A., Waller D.K., Hobbs C.A., et al. National Birth Defects Prevention Study. Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol 2009, [Epub ahead of print].
5. Verkleij-Hagoort A.C., Verlinde M., Ursem N.T., Lindemans J., Helbing W.A., Ottenkamp J., et al. Maternal hyperhomocysteinaemia is a risk factor for congenital heart disease. Br J Obstet Gynaecol 2006, 113:1412-1418.
6. Hobbs C.A., Malik S., Zhao W., James S.J., Melnyk S., Cleves M.A. Maternal homocysteine and congenital heart defects. J Am Coll Cardiol 2006, 47:683-685.
7. Huxley R., Barzi F., Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. Br Med J (Clin Res Ed.) 2006, 332:73-78.
8. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 1995, 274:1049-1057.
9. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Med Assoc 2001, 285:2486-2497.
10. Steegers-Theunissen R.P., Steegers E.A. Nutrient-gene interactions in early pregnancy: a vascular hypothesis. Eur J Obstet Gynecol Reprod Biol 2003, 106:115-117.
11. Khan I.Y., Dekou V., Douglas G., Jensen R., Hanson M.A., Poston L., et al. A high-fat diet during rat-pregnancy of suckling induces cardiovascular dysfunction in adult offspring. Am J Physiol Regul Integr Comp Physiol 2005, 288:R127-133.
12. Leeson C.P., Kattenhorn M., Morley R., Lucas A., Deanfield J.E. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation 2001, 103:1264-1268.
13. Innis S.M. Fatty acids and early human development. Early Hum Dev 2007, 83:761-766.
14. Devine C.M., Bove C.F., Olson C.M. Continuity and change in women's weight orientations and lifestyle practices through pregnancy and the postpartum period: the influence of life course trajectories and transitional events. Soc Sci Med 2000, 50:567-582.
15. Willet W. Nature of variation in diet. Nutritional epidemiology 1998, 33-50. Oxford University Press, New York, NY. W. Willet (Ed.).
16. Van Driel L.M.J.W., Zwolle L.J.H., de Vries J.H.M., Boxmeer J.C., Lindemans J., Steegers E.A.P., et al. The maternal nutritional status at one year after delivery is comparable with the preconception period. Reprod Sci March 2010, 16(Suppl. 3):239A. [abstract].
17. Potter J.M., Nestel P.J. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 1979, 133:165-170.
18. Lewis C.E., Funkhouser E., Raczynski J.M., Sidney S., Bild D.E., Howard B.V. Adverse effect of pregnancy on high density lipoprotein (HDL) cholesterol in young adult women. Am J Epidemiol 1996, 144:244-257.
19. Larsson A., Palm M., Hansson L.O., Axelsson O. Reference values for clinical chemistry tests during normal pregnancy. Br J Obstet Gynaecol 2008, 115:874-881.
20. Smedts H.P., Rakhshandehroo M., Verkleij-Hagoort A.C., de Vries J.H., Ottenkamp J., Steegers E.A., et al. Maternal intake of fat, riboflavin and nicotinamide and the risk of having offspring with congenital heart defects. Eur J Nutr 2008, 47:357-365.
21. Rosenquist T.H., Ratashak S.A., Selhub J. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci U S A 1996, 93:15227-15232.
22. Botto L.D., Mulinare J., Erickson J.D. Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gaps. Am J Med Genet 2003, 121:95-101.
23. Boot M.J., Steegers-Theunissen R.P., Poelmann R.E., van Iperen L., Gittenberger-de Groot A.C. Cardiac outflow tract malformations in chick embryos exposed to homocysteine. Cardiovasc Res 2004, 64:365-373.
24. Valkenburg O., Steegers-Theunissen R.P., Smedts H.P., Dallinga-Thie G.M., Fauser B.C., Westerveld E.H., et al. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab 2008, 93:470-476.
25. Statistics Netherlands Classification of educational level and ethnicity 2005, Voorburg/Heerlen, The Netherlands, [accessed 10.07.07]. http://www.cbs.nl/en-GB/meny/methoden/methoden-per-thema/default.thm.
26. Walldius G., Jungner I. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med 2004, 255:188-205.
27. Sattar N., Greer I.A. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. Br Med J 2002, 325:157-160.
28. Germain A.M., Romanik M.C., Guerra I., Solari S., Reyes M.S., Johnson R.J., et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?. Hypertension 2007, 49:90-95.
29. Napoli C., D'Armiento F.P., Mancini F.P., Postiglione A., Witztum J.L., Palumbo G., et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997, 100:2680-2690.
30. Benn M. Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review. Atherosclerosis 2009, 206:17-30.
31. Yoshida S., Wada Y. Transfer of maternal cholesterol to embryo and fetus in pregnant mice. J Lipid Res 2005, 46:2168-2174.
32. Demmer L.A., Levin M.S., Elovson J., Reuben M.A., Lusis A.J., Gordon J.I. Tissue-specific expression and developmental regulation of the rat apolipoprotein B gene. Proc Natl Acad Sci U S A 1986, 83:8102-8106.
33. Hopkins B., Sharpe C.R., Baralle F.E., Graham C.F. Organ distribution of apolipoprotein gene transcripts in 6-12 week postfertilization human embryos. J Embryol Exp Morphol 1986, 97:177-187.
34. Chechi K., McGuire J.J., Cheema S.K. Developmental programming of lipid metabolism and aortic vascular function in C57BL/6 mice: a novel study suggesting an involvement of LDL-receptor. Am J Physiol Regul Integr Comp Physiol 2009, 296:1029-1040.
35. Bruce K.D., Cagampang F.R., Argenton M., Zhang J., Ethirajan P.L., Burdge G.C., et al. Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. Hepatology 2009, 50:1796-1808.
36. Sibrian-Vazquez M., Escobedo J.O., Lim S., Samoei G.K., Strongin R.M. Homocystamides promote free-radical and oxidative damage to proteins. Proc Natl Acad Sci U S A 2010, 107:551-554.
37. Hobbs C.A., Cleves M.A., Zhao W., Melnyk S., James S.J. Congenital heart defects and maternal biomarkers of oxidative stress. Am J Clin Nutr 2005, 82:598-604.
38. Napoli C., Quehenberger O., De Nigris F., Abete P., Glass C.K., Palinski W. Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J 2000, 14:1996-2007.
39. de Nigris F., Youssef T., Ciafré S., Franconi F., Anania V., Condorelli G., et al. Evidence for oxidative activation of c-Myc-dependent nuclear signaling in human coronary smooth muscle cells and in early lesions of Watanabe heritable hyperlipidemic rabbits: protective effects of vitamin E. Circulation 2000, 102:2111-2117.
40. Ramos M.A., Kuzuya M., Esaki T., Miura S., Satake S., Asai T., et al. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1998, 18:1188-1196.